Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NU4

Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2007-03-15
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)0.8
Spacegroup nameP 21 21 2
Unit cell lengths57.769, 86.130, 46.284
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.200
R-factor0.1619
Rwork0.162
R-free0.20020
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)3nu3
RMSD bond length0.013
RMSD bond angle0.031
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareAMoRE
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.240
High resolution limit [Å]1.2001.200
Rmerge0.0810.442
Number of reflections66626
<I/σ(I)>2.5
Completeness [%]91.662.7
Redundancy6.13.4
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP5.4298The vapour diffusion, hanging drop method is applied. Amprenvir was dissolved in DMSO. Protein concentration is 2.2 mg/ml. The ratio of inhibitor to protein is 5:1 in 0.1 M sodium acetate buffer (ph=5.4), with 0.4M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon